Jan G. J. van de Winkel
E859164
Jan G. J. van de Winkel is a Dutch immunologist and biotech entrepreneur best known as the co-founder and long-time leader of the antibody-focused biotechnology company Genmab.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Jan G. J. van de Winkel canonical | 2 |
How this entity was disambiguated
This entity first appeared as the object of triple T10292234 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: Jan G. J. van de Winkel Context triple: [Genmab, foundedBy, Jan G. J. van de Winkel]
-
A.
Leendert van der Vlugt
Leendert van der Vlugt was a prominent Dutch modernist architect best known for co-designing the iconic Van Nelle Factory and helping define the Nieuwe Bouwen movement in the Netherlands.
-
B.
Johannes Hendrik Voskuijl
Johannes Hendrik Voskuijl was the father of Bep Voskuijl and one of the Dutch helpers who risked his life to support Anne Frank and the others hiding in the Secret Annex during World War II.
-
C.
Cornelis H. A. Koster
Cornelis H. A. Koster was a Dutch computer scientist known for his contributions to programming language design and formal language theory.
-
D.
Jurriaan de Jonge
Jurriaan de Jonge is an individual notable enough to be specifically cited as a bearer of the Dutch surname "de Jonge."
-
E.
Johan Adrianus G. van der Steur
Johan Adrianus G. van der Steur was a Dutch architect best known for his influential early 20th-century public and institutional buildings, including work on The Hague’s Peace Palace.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: Jan G. J. van de Winkel Target entity description: Jan G. J. van de Winkel is a Dutch immunologist and biotech entrepreneur best known as the co-founder and long-time leader of the antibody-focused biotechnology company Genmab.
-
A.
Leendert van der Vlugt
Leendert van der Vlugt was a prominent Dutch modernist architect best known for co-designing the iconic Van Nelle Factory and helping define the Nieuwe Bouwen movement in the Netherlands.
-
B.
Johannes Hendrik Voskuijl
Johannes Hendrik Voskuijl was the father of Bep Voskuijl and one of the Dutch helpers who risked his life to support Anne Frank and the others hiding in the Secret Annex during World War II.
-
C.
Cornelis H. A. Koster
Cornelis H. A. Koster was a Dutch computer scientist known for his contributions to programming language design and formal language theory.
-
D.
Jurriaan de Jonge
Jurriaan de Jonge is an individual notable enough to be specifically cited as a bearer of the Dutch surname "de Jonge."
-
E.
Johan Adrianus G. van der Steur
Johan Adrianus G. van der Steur was a Dutch architect best known for his influential early 20th-century public and institutional buildings, including work on The Hague’s Peace Palace.
- F. None of above. chosen
Statements (45)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology entrepreneur
ⓘ
business executive ⓘ human ⓘ immunologist ⓘ |
| associatedWith |
antibody-focused biotechnology
ⓘ
oncology drug development ⓘ |
| boardMemberOf | Genmab NERFINISHED ⓘ |
| businessSector |
immuno-oncology
ⓘ
oncology therapeutics ⓘ |
| citizenship | Netherlands NERFINISHED ⓘ |
| coFounderOf | Genmab NERFINISHED ⓘ |
| countryOfBusinessActivity |
Denmark
NERFINISHED
ⓘ
Netherlands NERFINISHED ⓘ United States NERFINISHED ⓘ |
| employer | Genmab NERFINISHED ⓘ |
| familyName | van de Winkel NERFINISHED ⓘ |
| fieldOfWork |
antibody therapeutics
ⓘ
biotechnology ⓘ immunology ⓘ |
| givenName | Jan NERFINISHED ⓘ |
| hasAcademicBackgroundIn |
biomedical sciences
ⓘ
immunology ⓘ |
| hasGender | male ⓘ |
| industry |
biopharmaceutical industry
ⓘ
biotechnology industry ⓘ |
| knownFor |
co-founding Genmab
ⓘ
leadership of Genmab ⓘ |
| languageSpoken | Dutch ⓘ |
| name | Jan G. J. van de Winkel NERFINISHED ⓘ |
| nationality | Dutch ⓘ |
| notableRole | long-time leader of Genmab ⓘ |
| notableWork |
development of antibody-based cancer therapies at Genmab
ⓘ
leadership in advancing antibody therapeutics to market ⓘ |
| occupation |
biotech entrepreneur
ⓘ
chief executive officer ⓘ immunologist ⓘ |
| positionHeld |
Chief Executive Officer of Genmab
ⓘ
Chief Scientific Officer of Genmab ⓘ President and CEO of Genmab ⓘ President of Genmab ⓘ |
| researchInterest |
antibody engineering
ⓘ
cancer immunotherapy ⓘ immune effector mechanisms ⓘ monoclonal antibodies ⓘ therapeutic antibodies ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: Jan G. J. van de Winkel Description of subject: Jan G. J. van de Winkel is a Dutch immunologist and biotech entrepreneur best known as the co-founder and long-time leader of the antibody-focused biotechnology company Genmab.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.